The efficacy and safety of pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl.
This study demonstrated that pravastatin 20 mg once daily significantly lowered total cholesterol (by 19%) and LDL cholesterol by 25%.